Reports › Supio review
Supio review (2026): what the published record shows
This Supio review is built from what the company publishes, not first-hand testing. Supio, founded 2021 in Seattle, is an agentic legal AI platform for plaintiff and mass tort firms: intake, medical chronologies, demand letters, litigation drafting, and case analytics, sold by subscription with no published rate or turnaround.
An assessment built from Supio’s published materials, captured and sourced in our Content Hub profile (verified 2026-08-28). Where a figure is not published, this page says so rather than estimate it. Nothing here comes from first-hand testing, and none of it is a Medrecords AI rating.
What Supio does
Supio’s published service lines cover the whole plaintiff-firm stack: agentic AI case intake automation, AI-generated medical chronologies, AI-generated demand letters, litigation drafting tools, case economics and ledger analysis, and firm intelligence with cross-case analytics for mass torts. It integrates with Westlaw and case management systems. The processing model is 100% AI (CaseAware) with human-validated accuracy benchmarks.
Key published facts
| Fact | What Supio publishes |
|---|---|
| Founded / HQ | 2021 · Seattle, WA |
| Headcount | 11–50 employees |
| Ownership | Private, venture-backed; Series B led by Sapphire Ventures |
| Processing model | 100% AI (CaseAware), human-validated benchmarks |
| Reviews | 4.8/5 from 57 G2 reviews (captured 13 Aug 2026) |
| Certifications | SOC 2 Type II, HIPAA, PHIPA, GDPR; US, UK, and Canada data centers |
| Pricing | Subscription (Case Subscription / Unlimited Firm Access); no published rate |
| Turnaround | Not published |
| Disclosure score | 5 of 8 rubric fields published |
Pricing: what is published
Supio names its two models, Case Subscription and Unlimited Firm Access, but publishes no rate for either. Every call to action on the captured site is “Book A Demo”; there is no self-serve signup or price list. Turnaround is likewise unpublished, so both cost and speed have to come out of a sales conversation.
How Supio compares
Medrecords AI sits in the same market with a different shape: records you upload are read in full, including scans, handwriting, and DICOM imaging, every output line links to its source page, and the price is published per page. Medrecords AI publishes its full rate: ten cents a page on Self-Service, duplicates free, with AI Enablement and On-Prem sold as annual licences. The dimension-by-dimension table is in the Medrecords AI vs Supio comparison.
For the wider field, the Supio alternatives page compares peer vendors on turnaround, human QA, pricing model, and published rate, built on the same published-materials rule as this review.
Upload a record and get a cited chronology back in minutes. You bring the file; a qualified reviewer stays the decision-maker.
Test a file →Frequently asked
Does Supio publish pricing?
No. It names two subscription models, Case Subscription and Unlimited Firm Access, but publishes no rate for either; every call to action on the captured site is a demo booking, with no self-serve signup or price list.
Who is Supio for?
Plaintiff personal injury and mass tort firms that want one platform across intake, chronologies, demand letters, litigation drafting, and case analytics. Teams that only need the record review layer are buying more platform than the task requires.
Is Supio accurate?
Supio publishes human-validated accuracy benchmarks for its 100% AI processing model and holds a 4.8/5 rating from 57 G2 reviews as of 13 Aug 2026. It does not publish page-level source citations, so plan your own verification workflow for contested matters.
Is this review based on first-hand testing?
No. This review is built from Supio’s own published materials as captured for our Content Hub profile (verified 2026-08-28), the same sourcing rule our comparison pages follow. Where a figure is not published we say so rather than estimate it, and nothing here is a Medrecords AI rating or score.